Fliz1 Activators
Chemical activators of Fliz1 include a variety of compounds that influence different cellular signaling pathways leading to the phosphorylation and consequent functional activation of the protein. Phorbol 12-myristate 13-acetate (PMA) directly activates Protein Kinase C (PKC), a kinase that plays a central role in cellular signaling by phosphorylating target proteins such as Fliz1. Similarly, forskolin acts by increasing intracellular cyclic AMP (cAMP) levels, which in turn activates Protein Kinase A (PKA) that can also target Fliz1 for phosphorylation. On the other side of phosphorylation regulation, inhibitors of protein phosphatases like Okadaic Acid and Calyculin A prevent the removal of phosphate groups from proteins, leading to sustained phosphorylation and activation of Fliz1. Ionomycin, by increasing intracellular calcium concentrations, can activate calcium-dependent protein kinases, which are capable of phosphorylating Fliz1. Anisomycin triggers the activation of stress-activated protein kinases, such as JNK, which might then phosphorylate Fliz1 as a part of the cellular stress response.
In addition to these direct activators of kinase activity, other compounds affect Fliz1 phosphorylation indirectly by perturbing cellular signaling networks. LY294002, by inhibiting PI3K, can lead to the activation of alternative kinases that may phosphorylate Fliz1. Rapamycin, known to inhibit the mTOR pathway, may also activate other kinase pathways that converge on Fliz1 phosphorylation. The cytokinin 6-Benzylaminopurine can activate kinases within its signaling pathways that phosphorylate Fliz1, while Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, potentially leading to the activation of kinases that would phosphorylate Fliz1. Lastly, dibutyryl-cAMP, a cAMP analog, ensures the activation of PKA, which then targets Fliz1 for phosphorylation, demonstrating the versatility of cellular signaling in modulating protein activity through phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
This compound is a protein phosphatase inhibitor that prevents dephosphorylation of proteins. By inhibiting phosphatases, Okadaic Acid can result in the sustained phosphorylation and thus functional activation of Fliz1, given that its activity is regulated by phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could then phosphorylate and activate Fliz1, as calcium signaling is a pivotal pathway for the regulation of numerous proteins and their activities. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A is also a phosphatase inhibitor that can prevent the dephosphorylation of proteins, potentially leading to the continued active state of Fliz1 through sustained phosphorylation, thereby functionally activating the protein. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, which may include kinase substrates or kinases themselves. This accumulation can enhance the phosphorylation and activation of Fliz1, as ubiquitination often regulates protein degradation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK. Activation of these kinases could lead to the phosphorylation and subsequent activation of Fliz1 as part of the cellular stress response, where protein activation is a common event. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can upregulate compensatory pathways, potentially leading to the activation of kinases that could phosphorylate and activate Fliz1 as part of the cellular response to maintain homeostasis in signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that may stimulate a compensatory response activating other kinases that could phosphorylate and activate Fliz1, as cells often activate alternative pathways to compensate for the inhibition of a major pathway like the mTOR signaling. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
A cytokinin that can activate specific signaling pathways and kinases which may lead to the phosphorylation and activation of Fliz1, as cytokinins are known to play a role in signaling events that regulate protein function and activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that increases cytosolic calcium levels, potentially leading to the activation of calcium-dependent kinases, which may phosphorylate and thus activate Fliz1, given that calcium signaling is crucial for the activation of many proteins. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA. PKA can then phosphorylate Fliz1, leading to its activation. The use of this analog ensures the activation of cAMP-dependent pathways, which can have widespread effects on cellular protein phosphorylation and activation. | ||||||